Antimycobacterial Agents
To view the entire topic, please log in or purchase a subscription.
The Washington Manual of Medical Therapeutics helps you diagnose and treat hundreds of medical conditions. Consult clinical recommendations from a resource that has been trusted on the wards for 50+ years. Explore these free sample topics:
-- The first section of this topic is shown below --
Effective therapy of Mycobacterium tuberculosis (MTB) infections requires combination chemotherapy to prevent the emergence of resistant organisms and maximize efficacy. Increased resistance to antituberculous agents has led to the use of more complex regimens and has made susceptibility testing an integral part of TB management (see Chapter 14, Treatment of Infectious Diseases).
-- To view the remaining sections of this topic, please log in or purchase a subscription --
Effective therapy of Mycobacterium tuberculosis (MTB) infections requires combination chemotherapy to prevent the emergence of resistant organisms and maximize efficacy. Increased resistance to antituberculous agents has led to the use of more complex regimens and has made susceptibility testing an integral part of TB management (see Chapter 14, Treatment of Infectious Diseases).
There's more to see -- the rest of this entry is available only to subscribers.